Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,459 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826.
Nishio S, Yonemori K, Usami T, Minobe S, Yunokawa M, Iwata T, Okamoto A, Aoki Y, Itamochi H, Takekuma M, Harano K, Yamamoto K, Maruko T, Ugai H, Tekin C, Colombo N, Fujiwara K, Hasegawa K, Ushijima K. Nishio S, et al. Among authors: aoki y. Cancer Sci. 2022 Nov;113(11):3877-3887. doi: 10.1111/cas.15479. Epub 2022 Sep 15. Cancer Sci. 2022. PMID: 35792064 Free PMC article. Clinical Trial.
Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial.
Umayahara K, Takekuma M, Hirashima Y, Noda SE, Ohno T, Miyagi E, Hirahara F, Hirata E, Kondo E, Tabata T, Nagai Y, Aoki Y, Wakatsuki M, Takeuchi M, Toita T, Takeshima N, Takizawa K. Umayahara K, et al. Among authors: aoki y. Gynecol Oncol. 2016 Feb;140(2):253-8. doi: 10.1016/j.ygyno.2015.12.008. Epub 2015 Dec 14. Gynecol Oncol. 2016. PMID: 26701414 Clinical Trial.
Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer.
Shimada M, Sato S, Oishi T, Itamochi H, Kigawa J, Takeshima N, Aoki D, Aoki Y, Nambu Y, Ochiai K. Shimada M, et al. Among authors: aoki y, aoki d. Int J Clin Oncol. 2016 Oct;21(5):969-974. doi: 10.1007/s10147-016-0984-y. Epub 2016 May 3. Int J Clin Oncol. 2016. PMID: 27142771
Phase II basket trial of perifosine monotherapy for recurrent gynecologic cancer with or without PIK3CA mutations.
Hasegawa K, Kagabu M, Mizuno M, Oda K, Aoki D, Mabuchi S, Kamiura S, Yamaguchi S, Aoki Y, Saito T, Yunokawa M, Takehara K, Okamoto A, Ochiai K, Kimura T. Hasegawa K, et al. Among authors: aoki y, aoki d. Invest New Drugs. 2017 Dec;35(6):800-812. doi: 10.1007/s10637-017-0504-6. Epub 2017 Sep 2. Invest New Drugs. 2017. PMID: 28864978 Clinical Trial.
Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer.
Aoki Y, Ochiai K, Lim S, Aoki D, Kamiura S, Lin H, Katsumata N, Cha SD, Kim JH, Kim BG, Hirashima Y, Fujiwara K, Kim YT, Kim SM, Chung HH, Chang TC, Kamura T, Takizawa K, Takeuchi M, Kang SB. Aoki Y, et al. Among authors: aoki d. Br J Cancer. 2018 Aug;119(5):530-537. doi: 10.1038/s41416-018-0206-7. Epub 2018 Aug 3. Br J Cancer. 2018. PMID: 30072745 Free PMC article. Clinical Trial.
Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program.
Matsumoto K, Yaegashi N, Iwata T, Yamamoto K, Aoki Y, Okadome M, Ushijima K, Kamiura S, Takehara K, Horie K, Tasaka N, Sonoda K, Takei Y, Aoki Y, Konnai K, Katabuchi H, Nakamura K, Ishikawa M, Watari H, Yoshida H, Matsumura N, Nakai H, Shigeta S, Takahashi F, Noda K, Yoshikawa H; MINT Study Group. Matsumoto K, et al. Among authors: aoki y. Cancer Sci. 2019 Dec;110(12):3811-3820. doi: 10.1111/cas.14212. Epub 2019 Nov 4. Cancer Sci. 2019. PMID: 31596999 Free PMC article.
Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan.
Onuki M, Matsumoto K, Iwata T, Yamamoto K, Aoki Y, Maenohara S, Tsuda N, Kamiura S, Takehara K, Horie K, Tasaka N, Yahata H, Takei Y, Aoki Y, Kato H, Motohara T, Nakamura K, Ishikawa M, Kato T, Yoshida H, Matsumura N, Nakai H, Shigeta S, Takahashi F, Noda K, Yaegashi N, Yoshikawa H. Onuki M, et al. Among authors: aoki y. Cancer Sci. 2020 Jul;111(7):2546-2557. doi: 10.1111/cas.14445. Epub 2020 May 21. Cancer Sci. 2020. PMID: 32372453 Free PMC article.
Adjuvant treatment of endometrial cancer today.
Aoki Y, Kanao H, Wang X, Yunokawa M, Omatsu K, Fusegi A, Takeshima N. Aoki Y, et al. Jpn J Clin Oncol. 2020 Jul 9;50(7):753-765. doi: 10.1093/jjco/hyaa071. Jpn J Clin Oncol. 2020. PMID: 32463094 Review.
Investigation of clinicopathological features of vulvar cancer in 1068 patients: A Japanese Gynecologic Oncology Group (JGOG) nationwide survey study.
Nishio S, Murotani K, Nakao S, Takenaka M, Suzuki S, Aoki Y, Todo Y, Hosaka M, Nakai H, Katabuchi H, Nishi H, Takekuma M, Mikami M, Enomoto T. Nishio S, et al. Among authors: aoki y. Gynecol Oncol. 2020 Nov;159(2):449-455. doi: 10.1016/j.ygyno.2020.08.019. Epub 2020 Aug 25. Gynecol Oncol. 2020. PMID: 32854973
3,459 results